Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Edogawa Evolutionary Laboratory of Science (EELS) is a research and translational medicine division of Edogawa Hospital, based in Tokyo, Japan. The laboratory specializes in regenerative medicine and cell-based therapies, utilizing its proprietary Thermoreversible-Gelation-Polymer (TGP) scaffold technology, also known as FESTIGEL. EELS has developed several innovative treatments, including BEES-HAUS for male urethral stricture and EELS-TALC for cartilage regeneration. The laboratory collaborates extensively with international partners like GN Corporation and the Nichi-In Centre for Regenerative Medicine (NCRM) to advance clinical applications in orthopedics, urology, ophthalmology, and oncology. Its research facility includes a high-tech biomaterial lab and cell culture R&D center dedicated to developing novel healthcare solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Edogawa Evolutionary Laboratory of Science.